The top 5 procedures performed in 2011 were:

• Breast augmentation (307,000 procedures)
• Rhinoplasty (nose reshaping; 244,000 procedures)
• Liposuction (205,000 procedures)
• Eyelid surgery (196,000 procedures)
• Facelift (119,000 procedures)

Minimally invasive procedures also saw an increase in 2011, up 6 percent. The most commonly performed minimally invasive procedures were Botulinum type A toxin injections (e.g. Botox, Dysport, etc.), soft tissue fillers (e.g. Juvederm, Restylane, Radiesse, Sculptra, etc.), chemical peel, laser hair removal and microdermabrasion.

To view the 2011 National Clearinghouse of Plastic Surgery Statistics report, visit www.plasticsurgery.org/2011-statistics. To schedule a consultation with Dr. Sam Jejurikar, contact the office at 214-827-2814.

For more information, do not hesitate to contact Dr. Jejurikar’s office at 214-827-2814.

Treatments that have been frequently used as well are nicotine replacement therapies, including nicotine patches and gums. In a study published yesterday, researchers from Harvard found that two-thirds of patients who quit smoking resumed smoking within four years, even when used in conjunction with behavioral modification. The study looked at nearly 800 patients and found the same relapse rate in people who used no smoking-cessation aids.

While the results of the study are certainly discouraging for patients looking to quit smoking permanently, the do not contradict the very real short term effects these products can have. Patients may be better off utilizing other forms of therapy, particularly medications such as Chantix and Zyban.

To learn more about plastic surgery at Dallas Plastic Surgery Institute, contact Dr. Jejurikar’s office at 214-827-2814. To learn more about this study, click this link.

An FDA advisory panel had previously voted 6-0 with 1 abstention that the benefits of using Restylane as an injection for lip augmentation outweighed its risks, and that the filler was safe and effective for this indication. The panel reviewed the results of a study of 135 patients who received Restylane and 45 patients with no treatment. Almost all patients (99%) experienced adverse events, which included bruising, redness, swelling, pain, tenderness, itching, and skin exfoliation. Of those who were treated, 15% experienced adverse events (typically swelling and tenderness) that lasted more than 15 days.

Restylane and Juvederm are the most commonly utilized hyaluronic acid fillers in the United States. To learn more about treatments with Restylane and Juvederm, contact Dr. Jejurikar’s office at Dallas Plastic Surgery Institute at 214-827-2814.

Symptoms of macromastia often include severe neck, shoulder and upper back pain, painful grooves from their bra straps, and rashes, wounds and infections (intertrigo) within the folds of their breasts. Although Dallas breast reduction has been demonstrated to alleviate symptoms associated with large breasts and improve quality-of-life, the amount of tissue required for excision to provide medical benefit has yet to be demonstrated. It is not uncommon for me to believe that a Dallas breast reduction will help my patient, only to have the patient’s insurance company disagree.

Breast reduction surgery is considered by the American Society of Plastic Surgeons to be medically necessary when symptoms of back pain, neck pain, shoulder pain, intertrigo, breast pain, and numbness of the extremities are documented and related to the patient’s large breasts. The recommendations of the ASPS are based on outcomes studies that essentially demonstrate no correlation between amount of breast tissue excised and relief of preoperative symptoms. Unfortunately, when symptoms are self-reported and subjective, it is difficult to determine medical necessity as, often, breast reduction is a cosmetic procedure. As a result insurance companies usually require extensive documentation of symptoms, as well clinical notes documenting failure of conservative treatment, including supportive bras, NSAIDs such as ibuprofen, physical therapy and chiropractic treatments. In addition, most insurance companies have a minimum tissue excision requirement that must be met to demonstrate medical necessity for Dallas breast reduction surgery.

If you’d like to learn more about Dallas breast reduction surgery, contact Dr. Jejurikar’s office at 214-827-2814 or via the Web.

Early reviews have been quite favorable. We are proud to offer Clear + Brilliant at EpiCentre Park Lane. Call today to schedule an appointment!

A mommy makeover performed at Dallas Plastic Surgery Institute usually takes between 4 and 7 hours and is performed under general anesthesia. Most patient’s stay overnight after Dallas mommy makeover in a postoperative recovery facility and miss between 1-2 weeks of work. No strenuous exercise is allowed for six to eight hours after surgery.

To try to cover the nuances of Dallas mommy makeover in more detail, we are proud to announce the re-release of www.mymommymakeoverdallas.com, our site dedicated to all things mommy makeover! To learn more, don’t hesitate to click on to the site or call our office to schedule a consultation with Dr. Jejurikar.

The reason for this recommendation is that, often, ruptured silicone breast implants are not detectable on physical examination. In these cases, MRI is the most sensitive method for detecting silicone breast implant rupture. Unfortunately, though, MRI can be an expensive exam and the costs usually are not covered by third-party insurance companies. Furthermore, the significance of a previously undetected silicone breast implant rupture is not clear, as it is not certain that the risks associated with ruptured implants is greater than the risks of the operation needed to take them out.

Last month, an expert FDA panel spent two days re-visiting the safety of silicone breast implants. The FDA’s chief scientist for devices, Dr. William Maisel, reaffirmed the safety of silicone breast implants. The panel agreed that patients no longer need to be told that they should get an MRI three years after getting silicone breast implants and every two years thereafter. The panel confirmed that MRI remains the gold standard for screening for silent breast implant rupture. This recommendation, however, has yet to be adopted by the FDA at large.

So what’s the conclusion? For now, the FDA recommendations from screening MRI three years after silicone breast augmentation and every two years thereafter remain intact. This guideline, though is a recommendation – not a requirement. Given the recommendations of the FDA’s expert panel, every patient should determine their own comfort level for living with a silent rupture, and make their own decision based on this.

For more information, please see the original article from the New York Times.